Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441777 · ClinicalTrials.gov registry record · NA
Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02441777: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT02441777 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02441777, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The aim of this pilot study is to assess the ability of a new polarization sensitive optical coherence tomography system to obtain high-quality images of retinal birefringence.
Interventions
- DEVICE Polarization-Sensitive OFDI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02441777
The ClinicalTrials.gov registry entry for NCT02441777 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polarization-Sensitive OFDI is the first listed.
NCT02441777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02441777 about?
NCT02441777 is a clinical study titled "Polarization Sensitive Optical Coherence Tomography (PS-OCT) for Retinal Imaging". The aim of this pilot study is to assess the ability of a new polarization sensitive optical coherence tomography system to obtain high-quality images of retinal birefringence.
What is the current status of trial NCT02441777?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06. Estimated completion is 2028-12.
What interventions are being tested in trial NCT02441777?
The interventions under investigation include: Polarization-Sensitive OFDI (DEVICE).
Who is sponsoring clinical trial NCT02441777?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.